Although CD44 and IL-33/ST2 have been well documented in human cancer metastasis or prognosis, respectively, evidence of the CD44 gene SNPs combined with IL-33/ST2 pathway functional polymorphisms in HCC susceptibility and clinical characteristics is scarce. Here, IL33 is linked to hepatocellular carcinoma.